Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic Dose Proportionality Study of OPL-002 in Healthy Volunteers

NCT04451811 is registered in ClinicalTrials.gov with Oppilan Pharma Ltd as lead sponsor.

NCT NCT04451811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04451811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic Dose Proportionality Study of OPL-002 in Healthy Volunteers
Lead sponsor
Oppilan Pharma Ltd
Phase
Phase 1
Overall status
Completed
Start date
September 7, 2020
Completion date
February 24, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy